#zyus search results
.IBHealth developed #ZYUS' brand name, new visual identity, messaging and positioning to frame a new category — positioning away from the #cannabis industry, toward a new proposition for leveraging plant-based science for good. goo.gl/6emhEh
I found you a Golden Cross on the daily chart of ANZ S&P 500 High Yield Low Volatility. $ZYUS #ZYUS #goldencross #bullish penketrading.com/symbols/ZYUS.A…
#Oyzik Une présentation choc de #Zyus V.empira Nous avons une petite idée de qui va passer au #WorldMasterySchool ㅡㅡㅡㅡㅡㅡㅡ #5Kyzov #Viktoria #Auguste #Upra Les empereurs honorifiques de leur dépense. Ils ont tout à gagner. #Vempira sur la piste.
.@IBHealth developed #ZYUS' brand name, new visual identity, messaging and positioning to frame a new category — positioning away from the #cannabis industry, toward a new proposition for leveraging plant-based science for good. goo.gl/6emhEh
The 1st ABIC Speaker Series featured SK's Brent Zettl sharing knowledge earned thru' growing a successful company: Business 101: Startup Bioscience. Worth a watch! youtube.com/watch?v=Kd2nq4… Don't miss the Sept28 ABIC lecture by Dr. Kevin Folta! agwestbio.member365.ca/public/event/d… #zyus #yxe
$HIP @newstrikeltd @updotca Providing access to a consistent supply of high-quality #medicalcannabis products for patients & healthcare providers in the domestic & int'l market is what will set #ZYUS apart... cannabisfn.com/zyus-and-up-ca… Sponsored content-view article for disclosure
@IBHealth developed #ZYUS' #brand name, new visual identity, messaging and positioning to frame a new category — positioning away from the #cannabis industry, toward a new proposition for leveraging #plantbased science for good. goo.gl/6emhEh
ZYUS Life Sciences Corporation Announces Closing of First Tranche of Unit Offering and Issuance of Warrants Pursuant to Previously Announced Loan Agreements and Promissory Note Amendment #ZYUS #TSXVZYUS #InvestorNews #LifeSciences zyus.com/news-and-event…
ZYUS Life Sciences Corporation Announces Closing of Secured Loan and Amendments to Prior Secured Promissory Note zyus.com/news-and-event… #ZYUS #LifeSciences #Biotech #ClinicalResearch #CannabinoidScience #PainManagement
Milestone for #ZYUS announced the activation of two additional clinical sites in its Phase 2a UTOPIA-1 cancer pain trial. Now 3 active sites enrolling patients across Canada. zyus.com/news-and-event… #cancerpain #Clinicaltrial #TSXV #LifeSciences
#ZYUS announces activation of Centre Hospitalier de l'Université de Montréal as the first site in its Phase 2a UTOPIA-1 trial for cancer pain. Advancing non-opioid innovation. bit.ly/4fUstCN #ClinicalTrial #Oncology #PainManagement #Biotech #CancerResearch
Yo @elonmusk, Mars’ta ZYUS ile susuzluk bitti! 🚀💧 Bu suyu roketine kadar biz getiririz, gerisi senin maceran. Ortaklık için ne dersin? #ZYUS #MarsWater #ElonX
ZYUS Life Sciences Finalizing Site Initiation for Phase 2A Clinical Trial Advancing Novel Non-Opioid Pain Drug bit.ly/3FjC6xb #ZYUS #Phase2Trial #Cannabinoids #InnovativeMedicine #OncologyResearch #PainManagement #ClinicalTrial #PressRelease #LifeSciences #Biotechnews
#ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management bit.ly/3xG7ba3 #PressRelease #ExcitingNews #Innovation #LifeSciences #PatentIssuance #InnovationInHealthcare #NonOpioidPainManagement #MedicalInnovation #PatientOutcomes #US
ZYUS is pleased to announce receipt of the final clinical study report and positive results respecting its Phase 1, first-in-human Clinical Trial for its lead drug product candidate, Trichomylin® softgels. #ZYUS #HealthcareInnovation #CannabinoidTherapies #ChronicPain
📣 Exciting news from ZYUS Life Sciences Corp zyus.com/news-and-event… #zyus #PressRelease #news #lifesciences #Innovation
#ZYUS is pleased to welcome renowned business leader, Wayne Brownlee to ZYUS’ Board of Directors. #ZYUS #BusinessNews #PressRelease #TSXV #clinicalresearch
#ZYUS commenced trading today on the TSX Venture Exchange (#tsxv), under the ticker symbol “ZYUS”. . . . #businessnews #canadiannews #lifesciences #stockmarket #stockexchange #trading
#ZYUS Life Sciences Corporation (the “Company”) has been approved by the TSX Venture Exchange (“TSX-V”) to commence trading on Monday, June 19, 2023, under the ticker symbol “ZYUS”. #TSXV bit.ly/46bWoBt
ZYUS Life Sciences Corporation Announces Completion of RTO #zyus #Biotechnology #RTO #PressRelease #CanadaNewsToday #lifesciences #clinicalresearch bit.ly/45WFCWJ
We’re hiring a Production Operator #zyus #hiring #Biotechnology #LifeSciences #CareerOpportunity zyus.com/careers/defaul…
Phoenix Canada Oil Company Limited Announces Successful Close of Subscription Receipt Financing Required for Reverse Takeover Transaction with ZYUS Life Sciences Inc. and Record Date for Warrant Distribution bit.ly/42nPDJv #pressrelease #zyus #Biotechnology #LifeSciences
ZYUS is celebrating its 5th anniversary! We look forward to the years ahead as ZYUS continues to Advance the Science of Well-being. #ZYUS #medicalcannabis #5years #CEO #Canada #Science #Lifesciences #Wellbeing
#ZYUS Announces Concurrent Private Placement of Subscription Receipts in Connection With Previously Announced RTO. bit.ly/3zfEIFA #businessnews #pressrelease #biotech #biotechnology #cannabisnews #RTO #announcement #newsrelease
Phoenix Canada Oil Company Limited (TSX-V: PCO) and #ZYUS Life Sciences Inc., together announce that they have received conditional approval from the TSX Venture Exchange. bit.ly/3Lotwhd #pressrelease #lifesciences #clinicalresearch #TSXV #biotech #TrendingNow
#Phoenix Canada Oil Company Limited and #ZYUS, together announce that they have entered into a Definitive Agreement dated November 15, 2022. #news #LifeSciences #business bit.ly/3tzDsdH
#ZYUS announced the successful completion of database lock for its Phase 1 #clinicaltrial to assess the safety, tolerability, and pharmacokinetics of Trichomylin® softgel capsules in healthy adult participants in Australia. #Press #cannabinoids bit.ly/3g4PgBw
#ZYUS is pleased to welcome renowned business leader, Wayne Brownlee to ZYUS’ Board of Directors. #ZYUS #BusinessNews #PressRelease #TSXV #clinicalresearch
ZYUS Life Sciences Corporation Announces Completion of RTO #zyus #Biotechnology #RTO #PressRelease #CanadaNewsToday #lifesciences #clinicalresearch bit.ly/45WFCWJ
Milestone for #ZYUS announced the activation of two additional clinical sites in its Phase 2a UTOPIA-1 cancer pain trial. Now 3 active sites enrolling patients across Canada. zyus.com/news-and-event… #cancerpain #Clinicaltrial #TSXV #LifeSciences
ZYUS Life Sciences Corporation Announces Closing of First Tranche of Unit Offering and Issuance of Warrants Pursuant to Previously Announced Loan Agreements and Promissory Note Amendment #ZYUS #TSXVZYUS #InvestorNews #LifeSciences zyus.com/news-and-event…
#ZYUS Life Sciences Corporation (the “Company”) has been approved by the TSX Venture Exchange (“TSX-V”) to commence trading on Monday, June 19, 2023, under the ticker symbol “ZYUS”. #TSXV bit.ly/46bWoBt
We’re hiring a Production Operator #zyus #hiring #Biotechnology #LifeSciences #CareerOpportunity zyus.com/careers/defaul…
ZYUS is pleased to announce receipt of the final clinical study report and positive results respecting its Phase 1, first-in-human Clinical Trial for its lead drug product candidate, Trichomylin® softgels. #ZYUS #HealthcareInnovation #CannabinoidTherapies #ChronicPain
📣 Exciting news from ZYUS Life Sciences Corp zyus.com/news-and-event… #zyus #PressRelease #news #lifesciences #Innovation
#ZYUS is pleased to introduce two new medical cannabinoid products, Zylem™ 1:20 Softgels and Zylem™ 5:5 Softgels - both for direct sales and distribution to registered medical cannabis patients across #Canada. bit.ly/3AMHToe #CannabisNews #press #newsalert
#ZYUS announced the successful completion of database lock for its Phase 1 #clinicaltrial to assess the safety, tolerability, and pharmacokinetics of Trichomylin® softgel capsules in healthy adult participants in Australia. #Press #cannabinoids bit.ly/3g4PgBw
#ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management bit.ly/3xG7ba3 #PressRelease #ExcitingNews #Innovation #LifeSciences #PatentIssuance #InnovationInHealthcare #NonOpioidPainManagement #MedicalInnovation #PatientOutcomes #US
I found you a Golden Cross on the daily chart of ANZ S&P 500 High Yield Low Volatility. $ZYUS #ZYUS #goldencross #bullish penketrading.com/symbols/ZYUS.A…
#ZYUS Announces Concurrent Private Placement of Subscription Receipts in Connection With Previously Announced RTO. bit.ly/3zfEIFA #businessnews #pressrelease #biotech #biotechnology #cannabisnews #RTO #announcement #newsrelease
ZYUS Life Sciences Finalizing Site Initiation for Phase 2A Clinical Trial Advancing Novel Non-Opioid Pain Drug bit.ly/3FjC6xb #ZYUS #Phase2Trial #Cannabinoids #InnovativeMedicine #OncologyResearch #PainManagement #ClinicalTrial #PressRelease #LifeSciences #Biotechnews
#Phoenix Canada Oil Company Limited and #ZYUS, together announce that they have entered into a Definitive Agreement dated November 15, 2022. #news #LifeSciences #business bit.ly/3tzDsdH
#ZYUS announces activation of Centre Hospitalier de l'Université de Montréal as the first site in its Phase 2a UTOPIA-1 trial for cancer pain. Advancing non-opioid innovation. bit.ly/4fUstCN #ClinicalTrial #Oncology #PainManagement #Biotech #CancerResearch
Phoenix Canada Oil Company Limited Announces Successful Close of Subscription Receipt Financing Required for Reverse Takeover Transaction with ZYUS Life Sciences Inc. and Record Date for Warrant Distribution bit.ly/42nPDJv #pressrelease #zyus #Biotechnology #LifeSciences
Phoenix Canada Oil Company Limited (TSX-V: PCO) and #ZYUS Life Sciences Inc., together announce that they have received conditional approval from the TSX Venture Exchange. bit.ly/3Lotwhd #pressrelease #lifesciences #clinicalresearch #TSXV #biotech #TrendingNow
.IBHealth developed #ZYUS' brand name, new visual identity, messaging and positioning to frame a new category — positioning away from the #cannabis industry, toward a new proposition for leveraging plant-based science for good. goo.gl/6emhEh
Something went wrong.
Something went wrong.
United States Trends
- 1. Daboll 29.9K posts
- 2. Pond 230K posts
- 3. Kim Davis 8,767 posts
- 4. Bowen 9,743 posts
- 5. #IDontWantToOverreactBUT 1,282 posts
- 6. Go Birds 8,834 posts
- 7. Schoen 14.7K posts
- 8. Marines 47.6K posts
- 9. #MYNZ 1,238 posts
- 10. Semper Fi 9,623 posts
- 11. Veterans Day 21K posts
- 12. Obergefell 5,675 posts
- 13. Edmund Fitzgerald 7,920 posts
- 14. #MondayMotivation 44.2K posts
- 15. Dart 35.1K posts
- 16. Giants 78.1K posts
- 17. Mike Kafka 1,268 posts
- 18. Correísmo Nunca Más N/A
- 19. #BudHolidayDelivery N/A
- 20. #USMC 2,648 posts